Schneider Lab
The Schneider Lab conducts translational cancer research at the Indiana University School of Medicine, under the direction of Dr. Bryan Schneider, MD. Dr. Schneider's research focuses on identifying genetic biomarkers to predict chemotherapy efficacy and the risk of chemotherapy induced side effects. Additionally, Dr. Schneider is the program founder of the Precision Genomics Clinic at IU Health,
12/03/2025
Enjoy some of our most recent team photos taken at the precision genomics clinic!
02/25/2025
Dr. Schneider presents our group's work, which was recently incorporated into the cancer guidelines (nccn.org), at the NCCN congress at Northwestern University in Chicago.
06/13/2024
Exciting news from the world of science!
Tarah Ballinger, MD, a dedicated researcher at IU School of Medicine, is making strides in breast cancer research. Notably, Dr. Ballinger has previously utilized KTB samples to delve into the intricacies of breast cancer.
Her recent work on the EAZ171 clinical trial is a testament to her commitment to advancing the field. Click the link to read about how Chemotherapy type can be personalized to decrease harmful side effects for Black patients with breast cancer: https://medicine.iu.edu/news/2024/06/eaz171-breast-cancer-study
Stay tuned for more updates as we continue to support and celebrate the incredible contributions of researchers like Dr. Ballinger in the fight against breast cancer.
Click here to claim your Sponsored Listing.
Category
Telephone
Address
980 W Walnut Street
Indianapolis, IN
46202
